Koers SoftOx Solutions AS Oslo Bors
Aandelen
NO0010811961
Biotechnologie & Medisch Onderzoek
Omzet 2021 | 7,9 mln. 740K 681K | Omzet 2022 | 7,11 mln. 666K 613K | Marktkapitalisatie | 241 mln. 22,57 mln. 20,76 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -65 mln. -6,09 mln. -5,6 mln. | Nettowinst (verlies) 2022 | -71 mln. -6,65 mln. -6,12 mln. | EV/omzet 2021 | 64,3 x |
Nettoliquiditeiten 2021 | 56,98 mln. 5,34 mln. 4,91 mln. | Nettoliquiditeiten 2022 | 6,91 mln. 647K 595K | EV/omzet 2022 | 32,9 x |
K/w-verhouding 2021 |
-8,86
x | K/w-verhouding 2022 |
-3,39
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 96,54% |
Recentste transcriptie over SoftOx Solutions AS
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | - | |
Geir Almås
FOU | Founder | - | 21-06-12 |
Harald Sætvedt
DFI | Director of Finance/CFO | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Olav Jarlsby
BRD | Director/Board Member | - | 17-04-15 |
Geir Almås
FOU | Founder | - | 21-06-12 |
Adrian Bignami
BRD | Director/Board Member | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,42% | 114 mld. | |
+11,84% | 104 mld. | |
-14,15% | 22,41 mld. | |
-1,05% | 22,28 mld. | |
-5,29% | 19,07 mld. | |
-38,29% | 18 mld. | |
-4,16% | 17,89 mld. | |
+7,99% | 14,28 mld. | |
+36,24% | 12,55 mld. |